GILEAD SCIENCES GILD (NASDAQ)

$ 52.70
19:10
Change: unch (unch%)
Volume: 12,927,313

Avg. Volume: 11721716
P/E Ratio: 27
EPS (Annual): 1.80
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 922,470
Institutional Shareholders: 90.57%
Last: 52.70
Change: unch (unch%)
Prev. Close: 52.70
Open: 51.43
Day's Range: 51.26 - 53.45
52wk Range: 35.22 - 56.95
Market Value: 45,689,892
Beta: .53
12-month EPS Change: -289.85%
Total Return Last 12 Months: +34.97%
Total Return Last 3 Years: +78.38%
Total Return Last 5 Years: +199.71%
5-Year Revenue Growth Rate: 806.20%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 1770.97%


Headlines on GILD
Alert me Subscribe

Gilead shares rise as new HIV study begins

(NEW YORK)Shares of biotechnology company Gilead Sciences Inc. rose Wednesday after the company said it started a late-stage study of a new HIV treatment candidate.READ MORE
Jul 23, 2008 8:16PM
Keywords: GILD, MRK

Movers roundup: Mirant, Merrill Lynch

Among the stock activity stories for Wednesday, July 23, from AP Financial News: NEW YORK (AP)--Shares of Mirant Corp. touched an 18-month low Wednesday after an analyst downgraded...READ MORE
Jul 23, 2008 6:25PM
Keywords: MIR, MERPO, BLK, GILD, CAT, CHRW, LECO

Movers roundup: Gilead Sciences, AMD

Among the stock activity stories for Friday, July 18, from the AP Financial News: NEW YORK (AP)_ Shares of Gilead Sciences Inc. fell sharply Friday as Wall Street viewed the drug d...READ MORE
Jul 18, 2008 4:02PM
Keywords: GILD, AMD, MAT

Gilead shares fall on 2Q report, growth concerns

(NEW YORK)Shares of Gilead Sciences Inc. fell sharply Friday as Wall Street viewed the drug developer's latest earnings report as sign that the company could be shifting to a more subdued le...READ MORE
Jul 18, 2008 11:32AM
Keywords: GILD

Earnings roundup: Microsoft, Google

Among the earnings stories for Thursday, July 17, from AP Financial News: Top stories:READ MORE
Jul 17, 2008 6:08PM
Keywords: MSFT, GOOG, NUE, ESLR, COF, GILD

Gilead 2Q profit rises on HIV drug sales

(FOSTER CITY, Calif.)Biotechnology company Gilead Sciences Inc. said Thursday its second-quarter profit rose 9 percent on sales of its HIV drugs Atripla and Truvada, which currently dominate the market...READ MORE
Jul 17, 2008 4:46PM
Keywords: GILD, BMY

Earnings Preview: Gilead Sciences

(NEW YORK)Gilead Sciences Inc. reports earnings for the second quarter on Thursday. The following is a summary of key developments and analyst opinion related to the period.READ MORE
Jul 16, 2008 11:38AM
Keywords: GILD, BMY, GSK
Blogs on GILD
Jul 22, 2008 11:50am
Analyst downgrades: TXN, SNDK and BRCD - BloggingStocks
Jul 21, 2008 9:09am
Cramer on BloggingStocks: Genentech bid confirms the trend - BloggingStocks
Jun 11, 2008 4:30pm
Short sellers letting up in biotechs - BloggingStocks
Apr 17, 2008 12:25pm
Gilead Sciences (GILD) reports higher Q1 profit but outlook disappoints - BloggingStocks
Apr 15, 2008 6:07pm
Gilead Sciences likes taking the lead in the sector - BloggingStocks
Mar 31, 2008 12:28pm
What the charts of these 20 stocks are trying to tell you - BloggingStocks
More Blogs >>
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

AMGEN +6.50 53.92
GILEAD SCIENCES +37.60 52.70
GENENTECH INC +36.30 93.73
CELGENE CP +22.00 70.45
BIOGEN IDEC INC +29.90 71.38